Alkem Laboratories Limited Appoints Vikas Gupta as the Chief Executive Officer, Effective 22nd September, 2023
September 15, 2023 at 07:38 am
Share
The Board of Directors of Alkem Laboratories Limited at its meeting held on 15th September, 2023 has appointed Dr. Vikas Gupta as the Chief Executive Officer (CEO) of the Company with effect from 22nd September, 2023. Dr. Vikas Gupta holds M.B.B.S degree from University College of Medical Sciences, Delhi University. He has over two decades of experience in Pharmaceutical Sector and brings with him deep experience across therapeutic areas including Acute, Chronic, Metabolic and Respiratory.
He also has demonstrated capability of leading business transformation across various geographies. His expertise includes delivering profitable and sustainable top line by driving teams, devising innovative sales & marketing plans and creating mega brands. He also has a proven track record of successfully launching new businesses as well as spearheading growth in established ones.
Alkem Laboratories Ltd. is an India-based pharmaceutical company with global operations, engaged in the development, manufacturing and sale of pharmaceutical and nutraceutical products. The Company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets. It has a portfolio of more than 800 brands in India. The Company also has a presence in more than 40 international markets, with the United States being its key focus market. Its offerings include therapies, Rx products and Alkem generic. Its therapy offerings include anti-infective, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory, rheumatology and urology. Its product portfolio also includes mega-brands such as Clavam, Pan, Pan-D, and Taxim-O. Under the Alkem Generics cluster there are four divisions: Futura, Maxxio, Novokem and Alkem Healthcare.
ALKEM LABORATORIES LIMITED 
